4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-021460
PRESIDENT AND CEO sold 15,625 shares at $37.56 ($586,927)
- PRESIDENT AND CEO acquired 15,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-14 | Option exercise 10b5-1 | +15,625 | $2.90 | $45,263 | 352,763 | D: show line 1 in the form |
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-14 | Sale 10b5-1 | −15,625 | $37.56 | $586,927 | 337,138 | D: show line 2 in the form |
| Open-market sales · 15,625 sh · avg $37.56 · $586,927 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-08-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 858,587 | D: show line 3 in the form |
Loading xslF345X05/form4-08162024_080827.xml…